Ampliphi Biosciences Corporation (NYSEAMERICAN:APHB) Stock Is Shorted More

September 16, 2018 - By Nellie Rakes

AmpliPhi Biosciences Corporation (NYSEAMERICAN:APHB) Logo

The stock of Ampliphi Biosciences Corporation (NYSEAMERICAN:APHB) registered an increase of 29.29% in short interest. APHB’s total short interest was 1.06 million shares in September as published by FINRA. Its up 29.29% from 821,200 shares, reported previously. With 151,100 shares average volume, it will take short sellers 7 days to cover their APHB’s short positions.

The stock decreased 8.65% or $0.09 during the last trading session, reaching $0.95. About 59,572 shares traded. AmpliPhi Biosciences Corporation (NYSEAMERICAN:APHB) has 0.00% since September 16, 2017 and is . It has underperformed by 15.62% the S&P500.

AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage technology. The company has market cap of $15.65 million. It is also developing targeted and personalized bacteriophage therapies for patients with serious or life-threatening antibiotic-resistant infections. It currently has negative earnings. The firm has reported results from two Phase I clinical trials of AB-SA01 for the treatment of Staphylococcus aureus in chronic rhinosinusitis patients, as well as evaluating the safety of AB-SA01 when administered topically to the intact skin of healthy adults.

AmpliPhi Biosciences Corporation (NYSEAMERICAN:APHB) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.